Rob Bowen is director of Facilities Integration, an architect led pharmaceutical consultancy specializing in masterplanning, concept design and design development.
Rob has spent over 35 years as a practicing Architect, more than 25 years of which have involved specializing in the design of complex specialist facilities. He is proud to call himself a process architect – a term not commonly recognized in the UK. He is a team worker by nature and works with clients and consultancy partners in the development and realization of new pharmaceutical manufacturing projects. Before founding the consultancy he was principal architect for Fluor Manufacturing and Life Sciences in Europe for nine years and prior to that with AMEC Projects (now Morgan Sindall PS) for seven years. Rob’s portfolio of work runs from R+D laboratories and specialist facilities through to designing clean manufacturing facilities for API and secondaries, packaging and distribution for chemical, biopharmaceutical, oral solid dose primary and secondaries based projects for generics and mainstream pharmaceutical companies in the UK, many European countries and the Near and Far East.
He is a past research fellow of the University of Warwick on an oral solid dose continuous processing study culminating in a design for a factory of the future. The overall study won the UK IChemE Outstanding and Project awards for 2012 for GSK, GEA, Siemens, Sagentia, and Warwick, Surrey and Newcastle universities.
He is a director of the UK Affiliate board for whom he reports on Communities of Practice. He has spoken on the urgent need for development of sustainable manufacturing facilities and the holistic introduction of sustainable technologies into the pharmaceutical industrial environment. In this respect he is ISPE’s global vice-chair of the sustainable facilities Community of Practice and leads the ISPE Handbook: Sustainability with Nick Haycocks. He has written several articles on continuous processing and sustainability, including for the PDA Letter and for Pharmaceutical Engineering. Otherwise he was a chapter lead on the 2013 ISPE Biopharmaceutical Facility Guide and has spoken at the UK IMechE on cleanroom topics, at ISPE and APV events in the UK and Europe.